Wen Fang Wu
Director/Board Member at ZHEJIANG ZOMAX TRANSMISSION CO., LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Qing Lin Liu | M | 55 | - | |
| Zheng Wu | M | 60 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 10 years |
| Zheng Fu Lin | M | 51 | 11 years | |
| Chen Hua Xu | F | 47 | 11 years | |
| Jian Fan | M | 41 | 2 years | |
| Xiang Yang Xu | M | 59 | - | |
| Hui Fang Yin | M | 39 | 2 years | |
| Yang Yu | M | 54 | 7 years | |
| Yi Fan Ni | M | 46 | 5 years | |
| Rui Lin Liang | M | 52 | 12 years | |
| Xiao Man Song | F | 63 | 6 years | |
| Ming Yang Yu | M | 60 | 2 years | |
| Min Min Yang | M | 52 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 3 years |
| Jun Li | M | 59 | - | |
| Sen Quan Zhang | M | 47 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 3 years |
| Ming Tian | M | 50 | - | |
| Gao Wang | M | 59 | 2 years | |
| Su Feng Zhang | F | 49 | 3 years | |
| Cheng Gu | M | 62 | 1 years | |
| Tao Yuan | M | 47 | 2 years | |
| Lin Gan | M | 51 | 3 years | |
| Shan Quan Liu | M | 49 | 2 years | |
| Wei Feng Gu | M | 47 | 4 years | |
| Run Dong Wang | M | 59 | 2 years | |
| Hai Qing Yuan | M | 58 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | - |
| Si Qun Ruan | M | 58 | 1 years | |
| Audrey Rao | F | 61 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 3 years |
| Tak Yuen Chan | M | 72 |
Renmin University of China
| 16 years |
| Wei Shen | M | 57 | 7 years | |
| Ye Qian Wang | F | 43 | 4 years | |
| Chang Chun Lin | M | - | - | |
| Gui Gen Lu | M | 62 | 5 years | |
| Jian Bu | M | 53 | 7 years | |
| Xu Bo Hu | M | 48 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | 4 years |
| Liang Xing Wu | M | 82 | 17 years | |
| Jiang Wu | M | 55 | 17 years | |
| Yu Jun Feng | M | 53 |
Renmin University of China
| 16 years |
| Jian Tao Zhang | M | - | - | |
| Zhi Kui Hu | M | 59 | 12 years | |
| Min Li Wu | M | 46 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chun Sheng Zhang | F | 61 | 16 years | |
| Guan Min Liao | M | 43 |
Renmin University of China
| 9 years |
| Jiu Gao Wang | M | 52 |
Renmin University of China
| 6 years |
| Lizhen Xie | M | 45 |
Zhongnan University of Economics & Law
| 7 years |
| Long Jie Qin | M | 53 | 2 years | |
| Shi Ming Shi | M | 45 |
Renmin University of China
Zhongnan University of Economics & Law
| 5 years |
| Xu Liu | M | 39 |
Renmin University of China
| 6 years |
| Si Hui Chen | F | 39 |
Zhongnan University of Economics & Law
| 4 years |
| Hao Gong | M | 50 | - | |
| Xi Lan Lü | F | 41 |
Zhongnan University of Economics & Law
| 3 years |
| Chengai Li | F | 44 |
Zhongnan University of Economics & Law
| 4 years |
| Yang Guo | M | 44 |
Jiangxi University of Finance & Economics
Zhongnan University of Economics & Law
| 6 years |
| Hua Tang | F | 57 |
Renmin University of China
| 2 years |
| Zi Ye Zhao | M | 44 | 3 years | |
| Wei Ping Yu | M | 53 |
Renmin University of China
| 6 years |
| Wen Qing Zhang | M | 61 | - | |
| Shiming Shi | M | 45 |
Renmin University of China
Zhongnan University of Economics & Law
| 7 years |
| Hong Jun Niu | M | 52 |
Renmin University of China
| - |
| Zilu Mao | F | 38 |
Renmin University of China
| 6 years |
| Gang Li | M | 44 |
Zhongnan University of Economics & Law
Renmin University of China
| 5 years |
| Yang Ling | M | 36 |
Renmin University of China
| 3 years |
| Wei Gang Liu | M | 38 |
Renmin University of China
| 4 years |
| Jing Xiang Sun | F | 42 |
Renmin University of China
| 4 years |
| Jian Zhang | M | 39 |
Renmin University of China
| 4 years |
| Yi Chi Zhang | M | 32 |
Renmin University of China
| 4 years |
| Rui Chen Yang | M | 39 |
Renmin University of China
| 2 years |
| Yu Feng He | M | 43 |
Zhongnan University of Economics & Law
| 4 years |
| Le Yu | M | 43 |
Renmin University of China
| 2 years |
| Chen Yu Lu | M | 47 |
Renmin University of China
| 4 years |
| Ze Jian Zhou | M | 41 |
Renmin University of China
| 1 years |
| Lei Yang | M | 37 |
Renmin University of China
| 3 years |
| Ryan Cui | M | - |
Renmin University of China
| 4 years |
| Li Li Wu | F | 42 |
Renmin University of China
| 4 years |
| Si Chen | F | 44 |
Renmin University of China
| 1 years |
| Cong Wang | M | 46 |
Renmin University of China
| 3 years |
| Ting Zheng | F | 52 |
Renmin University of China
| 2 years |
| Chun Gen Mao | M | 62 |
Renmin University of China
| 2 years |
| Guo Ming Zhang | M | 59 |
Renmin University of China
| 3 years |
| Zi Li Lei | M | 53 |
Zhongnan University of Economics & Law
| 2 years |
| Guo Bin Zhu | M | 62 |
Renmin University of China
| 3 years |
| Xiu Mei Zhao | F | 50 |
Renmin University of China
| 3 years |
| Xue Yun Ceng | M | 50 |
Renmin University of China
| 3 years |
| Long Wei | M | 54 |
Zhongnan University of Economics & Law
| 1 years |
| Yuan Yuan Zhao | F | - |
Renmin University of China
| 3 years |
| Ding Zheng Li | M | - |
Renmin University of China
| 4 years |
| Jia Wang Zhang | M | 45 |
Renmin University of China
| 2 years |
| Dong Hui Hu | F | 60 |
Renmin University of China
| 1 years |
| Qi Zhang Zhang | M | 39 |
Renmin University of China
| 4 years |
| Zhi Xiang Zhong | M | 58 |
Renmin University of China
| 3 years |
| Ye Gen Xie | M | 38 |
Renmin University of China
| 4 years |
| Zhen Dong Zhou | M | 34 |
Renmin University of China
| 4 years |
| Hua Xin | M | 48 |
Renmin University of China
| 2 years |
| Zheng Liang Zhao | M | 42 |
Renmin University of China
| 2 years |
| Tie Qiu Zheng | M | 40 |
Renmin University of China
| 1 years |
| Wei Zuo | M | - |
Zhongnan University of Economics & Law
| 4 years |
| Qing Deng | M | 43 |
Zhongnan University of Economics & Law
| 4 years |
| Xian Chen | F | 50 |
Renmin University of China
| 4 years |
| Chunling Li | M | 47 |
Renmin University of China
| 3 years |
| Jin Sheng Wang | M | 61 |
Renmin University of China
| 4 years |
| Wen Su | F | 45 |
Renmin University of China
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Wen Fang Wu
- Personal Network
